ANI Pharmaceuticals, Inc. (ANIP) reported fourth quarter net income to shareholders of $749 thousand compared to a loss of $4.65 million, last year. Profit per share was $0.04 compared to a loss of $0.28. Adjusted earnings per share was $1.00 compared to $0.76. On average, four analysts polled by Thomson Reuters expected the company to report profit per share of $0.85, for the quarter. Analysts' estimates typically exclude special items.
Net revenues increased to $131.65 million from $94.23 million, last year. Analysts on average had estimated $122.21 million in revenue.
For 2024, the company expects: net revenues of $520 million to $542 million, and adjusted non-GAAP earnings per share of $4.26 to $4.67.
https://www.rttnews.com/3428703/ani-pharmaceuticals-q4-profit-tops-estimates-revenues-up-39-7.aspx
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.